Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Nektar Therapeutics (NKTR)

Pharmaceutical Preparations

https://www.nektar.com

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, the company is focused on activating the immune system's natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/03/1994

Market Cap

224,576,380

Shares Outstanding

190,770,000

Weighted SO

190,770,566

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

ASMB --.--%

SPRO --.--%

ACHL --.--%

TIL --.--%

NLTX --.--%

CTMX --.--%

NXTC --.--%

NUVB --.--%

Beta

0.6670

Last Div

0.0000

Range

0.41-1.93

Chg

0.0300

Avg Vol

1820790

Mkt Cap

224576380

Exch

NASDAQ

Country

US

Phone

415 482 5300

DCF Diff

0.8876

DCF

3.4976

Div Yield

0.0000

P/S

2.4107

EV Multiple

-3.4282

P/FV

3.1971

Div Yield %

0.0000

P/E

-1.4387

PEG

-0.0545

Payout

0.0000

Current Ratio

5.1493

Quick Ratio

4.8970

Cash Ratio

0.2428

DSO

11.3586

DIO

138.9840

Op Cycle

150.3426

DPO

62.2137

CCC

88.1289

Gross Margin

0.5922

Op Margin

-1.5722

Pretax Margin

-1.9017

Net Margin

-1.9009

Eff Tax Rate

0.0004

ROA

-0.5158

ROE

-1.4259

ROCE

-0.5121

NI/EBT

0.9996

EBT/EBIT

1.2096

EBIT/Rev

-1.5722

Debt Ratio

0.3753

D/E

1.6168

LT Debt/Cap

0.5743

Total Debt/Cap

0.6179

Int Coverage

-12.3076

CF/Debt

-1.3564

Equity Multi

4.3085

Rec Turnover

32.1342

Pay Turnover

5.8669

Inv Turnover

2.6262

FA Turnover

3.8137

Asset Turnover

0.2713

OCF/Share

-0.8369

FCF/Share

-0.8398

Cash/Share

1.2988

OCF/Sales

-1.8760

FCF/OCF

1.0035

CF Coverage

-1.3564

ST Coverage

-8.1904

CapEx Coverage

-285.0865

Div&CapEx Cov

-285.0865

P/BV

3.1971

P/B

3.1971

P/S

2.4107

P/E

-1.4387

P/FCF

-1.2806

P/OCF

-1.4578

P/CF

-1.4578

PEG

-0.0545

P/S

2.4107

EV Multiple

-3.4282

P/FV

3.1971

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation